Biolevate raises €30M Series A and opens Boston office for its life sciences AI
The Next Web
Read the full article
Biolevate, a Paris-based AI startup focused on life sciences automation, raised €30M in Series A funding led by Orange Ventures and RAISE France, and opened a Boston office to expand in the US pharmaceutical market. The company’s AI platform accelerates regulatory workflows and is used by over a dozen enterprise clients, including Sanofi and Microsoft.
